Although direct evidence connecting IRF9 to BLCA is currently sparse, its function in regulating immune responses and potential interactions with other signaling molecules, such as TRAF5, could offer valuable insights into its role in cancer progression (Choi et al., 2024). This evidence concerns the gene IRF9 and cancer.